Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William O'Riordan

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infectionsWilliam O'Riordan, Purvi Mehra, Paul Manos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summaryWilliam O'Riordan, Sinikka Green, Purvi Mehra, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2018
Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO StudiesG Ralph Corey, Jeffery Loutit, Greg Moeck, et al.
Antimicrobial Agents and Chemotherapy|April 5, 2017
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsWilliam O'Riordan, Courtney Tiffany, Nicole Scangarella-Oman, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infectionPaul Covington, J Michael Davenport, David Andrae, et al.
American Journal of Surgery|December 20, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical proceduresSamuel E Wilson, William O'Riordan, Alan Hopkins, et al.
Stroke|August 22, 2009
Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) studyCarlos S Kase, Gregory W Albers, Christopher Bladin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2018
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized StudyWilliam O'Riordan, Alison McManus, Juri Teras, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2012
Efficacy of telavancin in patients with specific types of complicated skin and skin structure infectionsMartin E Stryjewski, Steven L Barriere, William O'Riordan, et al.
Lancet (London, England)|April 24, 2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonDavid G Sherman, Gregory W Albers, Christopher Bladin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infectionsWilliam O'Riordan, Purvi Mehra, Paul Manos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summaryWilliam O'Riordan, Sinikka Green, Purvi Mehra, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2018
Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO StudiesG Ralph Corey, Jeffery Loutit, Greg Moeck, et al.
Antimicrobial Agents and Chemotherapy|April 5, 2017
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsWilliam O'Riordan, Courtney Tiffany, Nicole Scangarella-Oman, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infectionPaul Covington, J Michael Davenport, David Andrae, et al.
American Journal of Surgery|December 20, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical proceduresSamuel E Wilson, William O'Riordan, Alan Hopkins, et al.
Stroke|August 22, 2009
Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) studyCarlos S Kase, Gregory W Albers, Christopher Bladin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2018
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized StudyWilliam O'Riordan, Alison McManus, Juri Teras, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2012
Efficacy of telavancin in patients with specific types of complicated skin and skin structure infectionsMartin E Stryjewski, Steven L Barriere, William O'Riordan, et al.
Lancet (London, England)|April 24, 2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparisonDavid G Sherman, Gregory W Albers, Christopher Bladin, et al.
Pageof 3